Why the study?
Does PDE3A reduction promote cardiomyocyte apoptosis in heart failure models?
Population
Human failing hearts, mouse hearts with chronic pressure overload, and primary cultured cardiomyocytes
Comparison
PDE3 inhibition, Angiotensin II, isoproterenol… vs Control conditions (untreated cells or hearts)
Design
Preclinical
Authors
Loading...
May explain mortality risk with chronic PDE3 inhibition in HF; hypothesis-generating for PDE3A restoration pending human studies.
Does PDE3A reduction promote cardiomyocyte apoptosis in heart failure models?
PDE3A reduction promotes cardiomyocyte apoptosis via inducible cAMP early repressor induction, providing a mechanistic explanation for why chronic PDE3 inhibition may increase mortality in heart failure.
Ding et al. (2005) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: